SARS-CoV-2 vaccine (Abera Bioscience)

N/A

Report date: 2025/09/04 16:17:08

Base Information

Drug NameSARS-CoV-2 vaccine (Abera Bioscience)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbera Bioscience AB
China Registration ClassN/A

Develop Information

Active CompaniesAbera Bioscience AB
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A